Literature DB >> 209117

A comparison of two methods to investigate the metabolism of human apolipoproteins A-I and and A-II.

J Shepherd, C J Packard, A M Gotto, O D Taunton.   

Abstract

Two methods are compared for measuring the kinetic parameters of apolipoprotein A-I and A-II metabolism in human plasma. In the first, high density lipoprotein apoproteins were radioiodinated in situ in the lipoprotein particle (endogenous apoprotein labeling) while in the second, individually labeled apolipoprotein A-I or A-II was incorporated into the particle by in vitro incubation (exogenous apoprotein labeling). The catabolic clearance rate of exogenously labeled apolipoprotein A-I was consistently faster than that of endogenous apolipoprotein A-I. Conversely, endogenously and exogenously labeled apolipoprotein A-II were catabolized at identical rates. The fractional plasma clearance rates of endogenous apolipoproteins A-I and A-II were the same.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 209117

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Setting the course for apoAII: a port in sight?

Authors:  Henry J Pownall; Baiba K Gillard; Antonio M Gotto
Journal:  Clin Lipidol       Date:  2013-10

2.  Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.

Authors:  L A Woollett; D K Spady
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

3.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.

Authors:  I J Goldberg; W S Blaner; T M Vanni; M Moukides; R Ramakrishnan
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

4.  Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Authors:  B S Horowitz; I J Goldberg; J Merab; T M Vanni; R Ramakrishnan; H N Ginsberg
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.

Authors:  J Shepherd; C J Packard; J R Patsch; A M Gotto; O D Taunton
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Evaluation of apolipoprotein A-I kinetics in rabbits in vivo using in situ and exogenous radioiodination methods.

Authors:  Bo Zhang; Eiso Shimoji; Hiroaki Tanaka; Keijiro Saku
Journal:  Lipids       Date:  2003-03       Impact factor: 1.880

7.  Hyperalphalipoproteinemia in human lecithin cholesterol acyltransferase transgenic rabbits. In vivo apolipoprotein A-I catabolism is delayed in a gene dose-dependent manner.

Authors:  M E Brousseau; S Santamarina-Fojo; L A Zech; A M Bérard; B L Vaisman; S M Meyn; D Powell; H B Brewer; J M Hoeg
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

8.  Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus.

Authors:  M R Taskinen; J Kahri; V Koivisto; J Shepherd; C J Packard
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

9.  Plasma clearance kinetics of the amyloid-related high density lipoprotein apoprotein, serum amyloid protein (apoSAA), in the mouse. Evidence for rapid apoSAA clearance.

Authors:  J S Hoffman; E P Benditt
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.